scholarly journals The dipeptidyl peptidase-4 inhibitor sitagliptin suppresses mouse colon tumorigenesis in type 2 diabetic mice

2015 ◽  
Vol 35 (2) ◽  
pp. 676-682 ◽  
Author(s):  
NAOKI YORIFUJI ◽  
TAKUYA INOUE ◽  
MUNETAKA IGUCHI ◽  
KAORI FUJIWARA ◽  
KAZUKI KAKIMOTO ◽  
...  
Keyword(s):  
Dipeptidyl Peptidase ◽  
Diabetic Mice ◽  
Dipeptidyl Peptidase 4 ◽  
Colon Tumorigenesis ◽  
Mouse Colon ◽  
Dipeptidyl Peptidase 4 Inhibitor ◽  
Type 2 Diabetic

Su2023 The Dipeptidyl Peptidase-4 Inhibitor, Sitagliptin, Suppresses Mouse Colon Tumorigenesis in Type 2 Diabetes Mice

2015 ◽  
Vol 148 (4) ◽  
pp. S-577
Author(s):  
Naoki Yorifuji ◽  
Takuya Inoue ◽  
Kaori Fujiwara ◽  
Munetaka Iguchi ◽  
Yuichi Kojima ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Dipeptidyl Peptidase ◽  
Dipeptidyl Peptidase 4 ◽  
Colon Tumorigenesis ◽  
Mouse Colon ◽  
Diabetes Mice ◽  
Dipeptidyl Peptidase 4 Inhibitor

scholarly journals Hypoglycemic effect and mechanism of isoquercitrin as an inhibitor of dipeptidyl peptidase-4 in type 2 diabetic mice

RSC Advances ◽  
2018 ◽  
Vol 8 (27) ◽  
pp. 14967-14974 ◽  
Author(s):  
Lei Zhang ◽  
Shi-Tao Zhang ◽  
Yan-Chun Yin ◽  
Shu Xing ◽  
Wan-Nan Li ◽  
...  
Keyword(s):  
Dipeptidyl Peptidase ◽  
Hypoglycemic Effect ◽  
Diabetic Mice ◽  
Dipeptidyl Peptidase 4 ◽  
L Cells ◽  
Gut Hormone ◽  
Glucagon Like Peptide ◽  
Type 2 Diabetic

Glucagon-like peptide (GLP)-1 is a potent glucose-dependent insulinotropic gut hormone released from intestinal L cells.

A dipeptidyl peptidase-4 inhibitor, sitagliptin, exerts anti-inflammatory effects in type 2 diabetic patients

Metabolism ◽  
2013 ◽  
Vol 62 (3) ◽  
pp. 347-351 ◽  
Author(s):  
Noriko Satoh-Asahara ◽  
Yousuke Sasaki ◽  
Hiromichi Wada ◽  
Mayu Tochiya ◽  
Azusa Iguchi ◽  
...  
Keyword(s):  
Dipeptidyl Peptidase ◽  
Diabetic Patients ◽  
Type 2 Diabetic Patients ◽  
Dipeptidyl Peptidase 4 ◽  
Dipeptidyl Peptidase 4 Inhibitor ◽  
Anti Inflammatory ◽  
Type 2 Diabetic
Sign in / Sign up

Export Citation Format

Share Document